AP9300576A0 - - Google Patents

Info

Publication number
AP9300576A0
AP9300576A0 AP939300576A AP9300576A AP9300576A0 AP 9300576 A0 AP9300576 A0 AP 9300576A0 AP 939300576 A AP939300576 A AP 939300576A AP 9300576 A AP9300576 A AP 9300576A AP 9300576 A0 AP9300576 A0 AP 9300576A0
Authority
AP
ARIPO
Application number
AP939300576A
Other versions
AP497A (en
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of AP9300576A0 publication Critical patent/AP9300576A0/xx
Application granted granted Critical
Publication of AP497A publication Critical patent/AP497A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
APAP/P/1993/000576A 1992-09-21 1993-09-21 Novel subcutaneous implants based on nomegestrol derivatives and the processes for their production. AP497A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Publications (2)

Publication Number Publication Date
AP9300576A0 true AP9300576A0 (sv) 1993-10-31
AP497A AP497A (en) 1996-05-28

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1993/000576A AP497A (en) 1992-09-21 1993-09-21 Novel subcutaneous implants based on nomegestrol derivatives and the processes for their production.

Country Status (31)

Country Link
US (1) US5565443A (sv)
EP (1) EP0613372B1 (sv)
JP (1) JPH08506318A (sv)
KR (1) KR100255700B1 (sv)
CN (1) CN1095667C (sv)
AP (1) AP497A (sv)
AT (1) ATE198275T1 (sv)
AU (1) AU683423B2 (sv)
BG (1) BG62317B1 (sv)
BR (1) BR9305642A (sv)
CA (1) CA2122827A1 (sv)
CZ (1) CZ284806B6 (sv)
DE (1) DE69329790D1 (sv)
DZ (1) DZ1717A1 (sv)
EC (1) ECSP930986A (sv)
FI (1) FI942272A (sv)
FR (1) FR2695826B1 (sv)
HU (1) HUT67044A (sv)
IL (1) IL107039A (sv)
MA (1) MA22978A1 (sv)
NO (1) NO306238B1 (sv)
OA (1) OA09924A (sv)
PL (1) PL176120B1 (sv)
RO (1) RO115783B1 (sv)
RU (1) RU2120797C1 (sv)
SK (1) SK54694A3 (sv)
TN (1) TNSN93104A1 (sv)
TW (1) TW381024B (sv)
WO (1) WO1994006437A1 (sv)
YU (1) YU60493A (sv)
ZA (1) ZA936964B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
BR0210722A (pt) 2001-06-29 2004-07-20 Medgraft Microtech Inc Implantes injetáveis biodegradáveis e métodos relacionados de produção e uso
SI2561860T1 (en) * 2002-05-31 2018-05-31 Titan Pharmaceuticals, Inc. An implantable polymeric device for prolonged release of buprenorphine
ZA200507877B (en) * 2003-03-31 2007-01-31 Titan Pharmaceuticals Inc Implantable polymeric device for sustained release of dopamine agonist
AU2004247057A1 (en) * 2003-05-30 2004-12-23 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of nalmefene
EP1670433B1 (en) 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
US8541028B2 (en) 2004-08-04 2013-09-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.

Also Published As

Publication number Publication date
JPH08506318A (ja) 1996-07-09
NO941900L (no) 1994-05-24
AU4822993A (en) 1994-04-12
FI942272A0 (sv) 1994-05-16
NO306238B1 (no) 1999-10-11
MA22978A1 (fr) 1994-04-01
CA2122827A1 (fr) 1994-03-31
EP0613372B1 (fr) 2000-12-27
BG98776A (bg) 1995-02-28
RU2120797C1 (ru) 1998-10-27
PL176120B1 (pl) 1999-04-30
TNSN93104A1 (fr) 1994-03-17
CN1094284A (zh) 1994-11-02
DZ1717A1 (fr) 2002-02-17
WO1994006437A1 (fr) 1994-03-31
BR9305642A (pt) 1996-01-09
SK54694A3 (en) 1994-10-05
AU683423B2 (en) 1997-11-13
KR100255700B1 (ko) 2000-08-01
CN1095667C (zh) 2002-12-11
ATE198275T1 (de) 2001-01-15
EP0613372A1 (fr) 1994-09-07
CZ284806B6 (cs) 1999-03-17
AP497A (en) 1996-05-28
IL107039A (en) 1999-01-26
ZA936964B (en) 1994-04-14
CZ116494A3 (en) 1995-03-15
RO115783B1 (ro) 2000-06-30
OA09924A (fr) 1994-09-15
FI942272A (sv) 1994-05-16
HUT67044A (en) 1995-01-30
FR2695826B1 (fr) 1995-01-06
TW381024B (en) 2000-02-01
BG62317B1 (bg) 1999-08-31
DE69329790D1 (de) 2001-02-01
NO941900D0 (no) 1994-05-20
ECSP930986A (es) 1994-04-12
IL107039A0 (en) 1993-12-28
US5565443A (en) 1996-10-15
FR2695826A1 (fr) 1994-03-25
HU9401395D0 (en) 1994-08-29
YU60493A (sh) 1997-01-08

Similar Documents

Publication Publication Date Title
TW253906B (sv)
TW243457B (sv)
DK0553875T3 (sv)
DK0553681T3 (sv)
DK0576346T3 (sv)
NO942904D0 (sv)
DK0574276T3 (sv)
TW277116B (sv)
DK0564197T3 (sv)
FR2692990B1 (sv)
DK0581726T3 (sv)
TW267240B (sv)
DK0576097T3 (sv)
TW276323B (sv)
FR2687467B1 (sv)
DE9207553U1 (sv)
TW272981B (sv)
IN178526B (sv)
IN185180B (sv)
IN180842B (sv)
AU1809592A (sv)
AU1007692A (sv)
AU1281292A (sv)
AU1053892A (sv)
AU1048992A (sv)